Literature DB >> 172007

Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens.

E D Ralph, W M Kirby.   

Abstract

The comparative bactericidal activity of penicillin G, carbenicillin, clindamycin, and metronidazole against eight susceptible strains of Bacteroides fragilis and four strains of Clostridium perfringens was determined by performing colony counts anaerobically of cultures incubated in brucella broth. With the B. fragilis strains, there was a lag phase of growth of approximately 8 h, during which time metronidazole did not reduce the colony counts. However, within 4 h of the onset of exponential growth, metronidazole caused an abrupt decrease in counts to less than 100 colonies per ml in all strains tested. Moreover, in two strains in which the bactericidal rate was followed hourly, a 3- to 6-log decrease occurred over 1 h or less. In contrast, penicillin G and carbenicillin caused a gradual decline in colony counts from the start of approximately 1 log for each 8-h interval and were bactericidal for all strains tested. Clindamycin demonstrated the slowest bactericidal activity and for 25% of the strains was only bacteriostatic. With the C. perfringens strains, after a lag phase of 4 h, an abrupt decrease in colony counts also occurred with metronidazole, whereas penicillin and clindamycin again demonstrated more gradual killing effects. These studies showed a unique, time-related bactericidal action of metronidazole as compared with the other three antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172007      PMCID: PMC429358          DOI: 10.1128/AAC.8.4.409

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.

Authors:  A W Chow; V Patten; L B Guze
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

2.  The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms.

Authors:  R M Ings; J A McFadzean; W E Ormerod
Journal:  Biochem Pharmacol       Date:  1974-05-01       Impact factor: 5.858

3.  The susceptibility of Bacteroides fragilis to 24 antibiotics.

Authors:  J W Kislak
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

4.  Pharmacokinetics of metronidazole as determined by bioassay.

Authors:  E D Ralph; J T Clarke; R D Libke; R P Luthy; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

5.  Pharmacokinetic studies of clindamycin phosphate.

Authors:  R M DeHaan; C M Metzler; D Schellenberg; W D Vandenbosch
Journal:  J Clin Pharmacol       Date:  1973 May-Jun       Impact factor: 3.126

6.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

7.  Speed of bactericidal action of penicillin G, ampicillin, and carbenicillin on Bacteroides fragilis.

Authors:  E Schoutens; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

8.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

9.  In vitro activity of penicillins against anaerobes.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

10.  Effects of l-(2-nitro-l-imidazolyl)-3-methoxy-2-propanol and 2-methyl-5-nitroimidazole-l-ethanol against anaerobic and aerobic bacteria and protozoa.

Authors:  H N Prince; E Grunberg; E Titsworth; W F DeLorenzo
Journal:  Appl Microbiol       Date:  1969-11
View more
  18 in total

1.  Antimicrobial activity of metronidazole in anaerobic bacteria.

Authors:  F P Tally; B R Goldin; N Sullivan; J Johnston; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.

Authors:  B Olsson; K Dornbusch; C E Nord
Journal:  Med Microbiol Immunol       Date:  1977-10-07       Impact factor: 3.402

Review 3.  Brain abscess in Saudi Arabia.

Authors:  A W Ibrahim; S M al-Rajeh; U M Chowdhary; A Ammar
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

4.  Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group.

Authors:  C W Stratton; L S Weeks; K E Aldridge
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

5.  Instillation of metronidazole into a brain abscess cavity.

Authors:  G Gentile; R Vagnozzi; R Giuffre; M Venditti; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

6.  Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.

Authors:  J Wust
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

7.  Kinetics of growth and toxigenicity of Clostridium botulinum in experimental wound botulism.

Authors:  M Dezfulian; J G Bartlett
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

8.  Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.

Authors:  P L Goldman; D T Durack; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

9.  Myocardial abscess with complete heart block complicating anaerobic infective endocarditis.

Authors:  H A Kopelman; B S Graham; M B Forman
Journal:  Br Heart J       Date:  1986-07

10.  [Antibiotic resistance of anaerobic bacteria (author's transl)].

Authors:  W Niederau; U Höffler; G Pulverer
Journal:  Infection       Date:  1982       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.